Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Targovax ASA (GB:0RIS)
LSE:0RIS
Holding GB:0RIS?
Track your performance easily
0RIS Stock Chart & Stats
Day’s Rangekr0 - kr0
52-Week Rangekr10.75 - kr10.75
Previous Closekr10.75
Volume0.00
Average Volume (3M)N/A
Market Cap
kr39.45M
Enterprise Valuekr39.91M
Total Cash (Recent Filing)kr62.97M
Total Debt (Recent Filing)kr63.42M
Price to Earnings (P/E)12.5
Beta0.63
Next Earnings
Feb 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.86
Shares Outstanding6,420,140
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation1.51
R-Squared0.02
Alpha0.18
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)11.19
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Targovax ASA News
PremiumCompany Announcements
Circio CTO Exercises Warrants Amidst RNA Tech Advances
PremiumCompany Announcements
Circio Holding ASA Expands Share Capital Amid Therapeutics Focus
PremiumCompany Announcements
Circio CEO Exercises Warrants Amid Biotech Advancements
PremiumCompany Announcements
Circio Advances RNA Therapeutics and Cancer Vaccine
PremiumCompany Announcements
Circio Holding ASA Unveils RNA Technology UpdatesPremiumCompany Announcements
Circio Holding ASA Issues Stock Options to Key Employees
PremiumCompany Announcements
Targovax ASA Partners with Certest for Gene Therapy Innovation
PremiumCompany Announcements
Circio Holding ASA Boosts Share Capital and Advances RNA Therapeutics0RIS FAQ
What was Targovax ASA’s price range in the past 12 months?
Targovax ASA lowest share price was kr10.75 and its highest was kr10.75 in the past 12 months.
What is Targovax ASA’s market cap?
Currently, no data Available
When is Targovax ASA’s upcoming earnings report date?
Targovax ASA’s upcoming earnings report date is Feb 13, 2025 which is in 63 days.
How were Targovax ASA’s earnings last quarter?
Currently, no data Available
Is Targovax ASA overvalued?
According to Wall Street analysts Targovax ASA’s price is currently Overvalued.
Does Targovax ASA pay dividends?
Targovax ASA does not currently pay dividends.
What is Targovax ASA’s EPS estimate?
Targovax ASA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Targovax ASA have?
Targovax ASA has 52,325,650 shares outstanding.
What happened to Targovax ASA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Targovax ASA?
Currently, no hedge funds are holding shares in GB:0RIS
---
Targovax ASA Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-85.01%
Trailing 12-Months
Company Description
Targovax ASA
Targovax ASA is a clinical-stage company. It is focused on developing and commercializing immuno-oncology therapies to target treatment-resistant solid tumors. Its product candidate, ONCOS-102, is a genetically modified oncolytic adenovirus, which has been engineered to infect cancer cells and activate the immune system to fight cancer.
---
Technical Analysis
---